Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Chemed Corporation    CHE

CHEMED CORPORATION

(CHE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/14/2020 02/18/2020 02/19/2020 02/20/2020 02/21/2020 Date
491.69(c) 491.58(c) 507.2(c) 487.26(c) 485.56(c) Last
159 829 125 997 167 968 115 138 120 105 Volume
+0.01% -0.02% +3.18% -3.93% -0.35% Change
More quotes
Financials (USD)
Sales 2020 2 141 M
EBIT 2020 341 M
Net income 2020 259 M
Finance 2020 35,9 M
Yield 2020 0,26%
Sales 2021 2 303 M
EBIT 2021 364 M
Net income 2021 274 M
Finance 2021 182 M
Yield 2021 0,28%
P/E ratio 2020 31,0x
P/E ratio 2021 29,4x
EV / Sales2020 3,61x
EV / Sales2021 3,30x
Capitalization 7 773 M
More Financials
Company
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients... 
More about the company
Surperformance© ratings of Chemed Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on CHEMED CORPORATION
02/21CHEMED CORPORATION : Declares Quarterly Dividend of 32 Cents
BU
02/18CHEMED : 4Q Earnings Snapshot
AQ
02/18CHEMED CORP : Results of Operations and Financial Condition, Financial Statement..
AQ
02/18CHEMED : Reports Fourth-Quarter 2019 Results
BU
02/13CHEMED CORPORATION : annual earnings release
01/20CHEMED : To Report Fourth-Quarter 2019 Earnings February 18, Related Conference ..
BU
2019UK building sector hit by surge in insurance costs after Grenfell fire
RE
2019CHEMED CORPORATION : Ex-dividend day for
FA
2019CHEMED CORPORATION : to Present at the 2019 Credit Suisse Healthcare Conference
BU
2019CHEMED : Management's Discussion and Analysis of Financial Condition and Results..
AQ
2019CHEMED CORPORATION : Declares Quarterly Dividend of 32 Cents
BU
2019CHEMED CORP : Results of Operations and Financial Condition, Financial Statement..
AQ
2019CHEMED : 3Q Earnings Snapshot
AQ
2019CHEMED : Reports Third-Quarter 2019 Results
BU
2019CHEMED : To Report Third-Quarter 2019 Earnings October 29, Related Conference Ca..
PU
More news
News in other languages on CHEMED CORPORATION
02/13CHEMED CORPORATION : Veröffentlichung des Jahresergebnisses
02/13CHEMED CORPORATION : publication des résultats annuels
2019CHEMED CORPORATION : Ex-dividend day for
2019CHEMED CORPORATION : Ex-dividend day for
2019CHEMED CORPORATION : Ex-dividend day for
More news
Analyst Recommendations on CHEMED CORPORATION
More recommendations
Sector news : Healthcare Facilities & Services - NEC
02/23PHYSICIANS, HOSPITALS MEET THEIR NEW : Insurer-Owned Clinics
DJ
02/20Fresenius forecasts 2020 profit growth driven by drug, dialysis units
RE
02/20Fresenius 4Q Net Profit Flat; Creates JV With Vifor in China
DJ
02/19FRESENIUS MEDICAL CARE : says fourth-quarter operating profit up 3%
RE
02/19FRESENIUS : Subsidiary to Acquire Hospital in Bogota
DJ
More sector news : Healthcare Facilities & Services - NEC
Chart CHEMED CORPORATION
Duration : Period :
Chemed Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHEMED CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 504,20  $
Last Close Price 485,56  $
Spread / Highest target 15,3%
Spread / Average Target 3,84%
Spread / Lowest Target -12,7%
EPS Revisions
Managers
NameTitle
Kevin J. McNamara President, Chief Executive Officer & Director
George J. Walsh Chairman
Scott William Rook Chief Operating Officer
David Patrick Williams Chief Financial Officer & Executive Vice President
Joel F. Gemunder Independent Director
Sector and Competitors